Indus Biotech Profile
Key Indicators
- Authorised Capital ₹ 43.00 Cr
as on 15-07-2024
- Paid Up Capital ₹ 15.77 Cr
as on 15-07-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.97 Cr
as on 15-07-2024
- Satisfied Charges ₹ 22.02 Cr
as on 15-07-2024
About Indus Biotech
The Corporate was formerly known as Indus Natural Products Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 43.00 Cr and a paid-up capital of Rs 15.77 Cr.
The company currently has active open charges totaling ₹12.97 Cr. The company has closed loans amounting to ₹22.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indus Biotech Limited India are Achyut Huilgol as CFO and Rucha Khaire as Company Secretary. Anil Kumar, Rajan Srinivasan, Ranjeet Srinivasan, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231MH1995PLC085656
- Company No.
085656
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Feb 1995
- Date of AGM
15 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indus Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Achyut Huilgol  | CFO | 14-Mar-2018 | Current |
| Sunil Bhaskaran | Managing Director | 16-Feb-1995 | Current |
| Rucha Khaire | Company Secretary | 19-Jun-2017 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Himanshu Nivsarkar | Nominee Director | 24-Mar-2017 | Current |
| Anil Kumar | Director | 15-Nov-2021 | Current |
| Rajan Srinivasan | Director | 01-Jan-2001 | Current |
| Ranjeet Srinivasan | Director | 16-Feb-1995 | Current |
| Shrikant Patil | Director | 15-Nov-2021 | Current |
Financial Performance of Indus Biotech.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Indus Biotech?
Unlock access to Indus Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Argon Company Connectivity Services Private LimitedActive 25 years 10 monthsRajan Srinivasan is a mutual person
Mithi Software Technologies Private LiimitedActive 31 years 7 monthsShrikant Patil is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Jun 2021 | ₹12.04 Cr | Open |
Vijaya Bank Creation Date: 15 Jun 2017 | ₹9.27 M | Open |
Others Creation Date: 27 Oct 2015 | ₹13.48 Cr | Satisfied |
How Many Employees Work at Indus Biotech?
Unlock and access historical data on people associated with Indus Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
